Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Free Cash Flow (2023 - 2025)

Cannabis Bioscience International Holdings' Free Cash Flow history spans 3 years, with the latest figure at -$5493.0 for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 92.38% year-over-year to -$5493.0; the TTM value through Nov 2025 reached -$336329.0, down 17.59%, while the annual FY2025 figure was -$329627.0, 31.24% up from the prior year.
  • Free Cash Flow for Q4 2025 was -$5493.0 at Cannabis Bioscience International Holdings, up from -$103712.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$5493.0 in Q4 2025 and bottomed at -$221247.0 in Q4 2023.
  • The 3-year median for Free Cash Flow is -$93262.0 (2025), against an average of -$108937.0.
  • The largest annual shift saw Free Cash Flow surged 95.49% in 2024 before it crashed 812.43% in 2025.
  • A 3-year view of Free Cash Flow shows it stood at -$221247.0 in 2023, then skyrocketed by 67.42% to -$72090.0 in 2024, then soared by 92.38% to -$5493.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Free Cash Flow are -$5493.0 (Q4 2025), -$103712.0 (Q3 2025), and -$144312.0 (Q2 2025).